Home » Active Pharmaceuticals Ingredients » Rapaglinide
| Product Name | Rapaglinide BP/EP/USP |
| Chemical Name | (S)-(+)-2-ethoxy-4-[2-(3-methyl-1-[2-(piperidin-1-yl)phenyl]butylamino)-2-oxoethyl]benzoic acid |
| CAS Number | 135062-02-1 |
| Chemical Formula | C27H36N2O4 |
| Molecular Mass | 452.58 g/mol |
| Therapeutic Category | antidiabetic |
| Product Name | Residronate Sodium BP/EP/USP |
| Chemical Name | 1-hydroxy-2-(3-pyridinyl)ethylidene]bis[phosphonic acid] |
| CAS Number | 115436-72-1 |
| Chemical Formula | C7H10NNaO7P2 |
| Molecular Mass | 305.09 g/mol |
| Therapeutic Category | Bisphosphonate |
| Melting point | 252-262 Degree C |
| Boiling point | 692.3 Degree C |
| Product Name | Rosuvastatin Calcium BP/EP/USP |
| Chemical Name | 7 - [4 - (4 - fluorophenyl) - 6 - (1 - methylethyl) - 2 - [methylsulfonyl)amino] - 5 - pyrimi - dinyl] - 3,5 - dihydroxy - 6 - heptenoic acid calcium |
| CAS Number | 147098-20-2 |
| Chemical Formula | 2C22H27FN3O6S • Ca |
| Molecular Mass | 1001.14 g/mol |
| Therapeutic Category | HMG-CoA Reductase Inhibitors |
Specification of Rosuvastatin Calcium :
| Test | Specification |
| Description | A white to creamish colour powder. |
| Solubility | Soluble in 100 parts of N,N-Dimethyl Formamide |
| Identification a) By I.R. b)By HPLC |
I.R. spectrum should be identical to that of standard Retention time of the sample peak should corresponds to that of standard |
| Water by K.F. (in DMF) | NMT 8.0%w/w |
| Calcium Content | 3.0% - 5.0%w/w |
| Related Substances (by HPLC) a) Max. Single Impurity b) Total Impurities |
NMT 1.0% NMT 2.0% |
| Assay (HPLC,OAB) | NLT 97% w/w |
Our Product Range : Active Pharmaceuticals Ingredients |Drug Intermediates | Finished Formulation
Home|About Us|Our Product Range|Media Gallery|Contact Us|Enquiry
©
Yashica Pharmaceuticals Private Limited. All Rights Reserved (Terms
of Use)
